Pear Therapeutics – Medical Alley Association
Pear Therapeutics

In the Know: Healthcare News for September 20, 2021

Francis Medical Announces Close of $55 Million Series B Equity Financing Flywheel Raises $22M in Series C Funding Makana Therapeutics Awarded KidneyX Artificial Kidney Prize for Innovation in Xenotransplantation NeuroOne® Medical Technologies Corporation Receives FDA 510(k) Clearance for its Evo® sEEG Electrode Packaging Maker Relocates HQ to Maple Grove from Plymouth Mitesco Announces Lease for […]

In the Know: Healthcare News for August 30, 2021

Allina Health | Aetna Welcomes New COO, Monica Nierengarten Humanetics Corporation’s BIO 300 Receives Fast Track Designation from FDA NeuroOne Announces Strategic Partnership with RBC Medical Innovations for Ablation Program University of Minnesota part of $15M Great Lakes innovation hub Maple Grove Medical Device Startup Shows Long Road to FDA Approval Mayo Clinic Partners with […]

In the Know: Healthcare News for August 16, 2021

Boston Scientific Gets FDA Nod for Single-Use Bronchoscope, Sees $2B Opportunity New Model Allows 3M Employees To Choose How And Where They Work Halma Completes Three Acquisitions and One Disposal Aligned with its Purpose Aldevron’s Collaboration with Ginkgo Bioworks Yields Manufacturing Breakthrough for Vaccinia Capping Enzyme Used for Manufacturing of mRNA Vaccines Miromatrix Announces Key […]

In the Know: Healthcare News for July 19, 2021

Peter Arduini Named CEO of GE Healthcare Medtech Veteran Martha Shadan Joins CVRx Board of Directors Vyant Bio Announces Issuance of Key Patent for High-Throughput Optical Assay of Human Mixed Cell Population Spheroids Provation and the Australian Commission on Safety and Quality in Health Care Strive to Improve Colonoscopy Documentation with New Requirements and Technology […]

Pear Therapeutics and Serve You Rs Announce Formulary Coverage for Prescription Digital Therapeutic Somryst and People With Chronic Insomnia

Boston and Milwaukee, June 23, 2021– Pear Therapeutics, Inc. and Serve You Rx announced today that Somryst®, the only FDA-authorized prescription digital therapeutic for the treatment of chronic insomnia, will be added to Serve You Rx’s formularies and be administered as a standard pharmacy benefit for its members, effective July 1, 2021. Somryst, intended for use in the treatment […]

Pear Therapeutics Announces First Participant Enrolled in National Institutes of Health Clinical Trial Investigating Combinations of Pharmacological and Behavioral Interventions to Treat Opioid Use Disorder

Boston and San Francisco – Pear Therapeutics, Inc. today announced the first participant enrolled in the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN)-0100 study on optimizing retention, duration, and discontinuation strategies for pharmacotherapy treatment of opioid use disorder (OUD), using Pear’s prescription digital therapeutic (PDT) reSET-O®.  Investigators will study reSET-O, in conjunction with high- and standard-dose transmucosal […]

In The Know: Healthcare News for June 28

Bright Health Raises $924M, Making it the Largest IPO Ever in Minnesota Miromatrix stock up over 60% after IPO raises $43 million Silicon Valley-Based Silk Road Medical Announces Expansion to MSP Region Pear Therapeutics to Become a Public Company and Expand its Leadership Position in Prescription Digital Therapeutics Nu-Tek BioSciences Building $40 Million Peptone Factory […]

In The Know: Healthcare News for May 17, 2021

Relievant Medsystems Names Tyler Binney President and CEO Value-Based Care Innovator Lifesprk to Acquire Tealwood Senior Living; Bill Thomas to Lead Creation of Operational Model Mayo Clinic, Kaiser Permanente Announce Strategic Investment in Medically Home to Expand Access to Serious or Complex Care at Home NAMSA in Growth Mode Under New Leadership Bigfoot Biomedical® Receives […]

PEAR ANNOUNCES OHIO DEPARTMENT OF MENTAL HEALTH AND ADDICTION SERVICES WILL PROVIDE ACCESS TO PRESCRIPTION DIGITAL THERAPEUTICS TO HELP LOCAL COMMUNITIES CONTINUE FIGHT AGAINST OPIOID ADDICTION

Columbus, OH, Boston and San Francisco, April 22, 2021 – Pear Therapeutics, Inc. announced today that the Ohio Department of Mental Health and Addiction Services (OhioMHAS) and RecoveryOhio are providing access to Pear’s FDA-authorized prescription digital therapeutics (PDTs) reSET® and reSET-O® for the treatment of substance use disorder (SUD) and opioid use disorder (OUD), respectively. Eligible patients will be prescribed and treated […]

NORTHWELL HEALTH TEAMS WITH PEAR THERAPEUTICS TO PROVIDE NEW TREATMENT FOR PATIENTS WITH SUBSTANCE USE DISORDERS

NEW HYDE PARK, NY, April 20, 2021 –Patients seeking treatment for opioid and substance use disorders will now have access to an innovative FDA-authorized treatment option—prescription digital therapeutics (PDTs)— thanks to a collaboration between Northwell Health and Pear Therapeutics, Inc. Northwell will be providing digital care to patients by offering access to Pear’s reSET® and reSET-O® PDTs through the substance […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER